Futura Medical (LON:FUM) Trading Down 5% – Here’s What Happened

Posted by Caroline Horne on Oct 15th, 2024

Futura Medical plc (LON:FUM – Get Free Report)’s stock price traded down 5% during trading on Tuesday . The company traded as low as GBX 30 ($0.39) and last traded at GBX 31.67 ($0.41). 765,839 shares traded hands during trading, an increase of 27% from the average session volume of 602,253 shares. The stock had previously closed at GBX 33.33 ($0.44).

Futura Medical Price Performance

The firm has a market capitalization of £91.32 million, a PE ratio of -3,332.50 and a beta of 1.25. The company has a 50-day moving average price of GBX 35 and a 200 day moving average price of GBX 36.35.

Insider Buying and Selling

In related news, insider James Henry Barder sold 250,000 shares of the company’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of GBX 41 ($0.54), for a total transaction of £102,500 ($133,846.96). 32.14% of the stock is owned by insiders.

Futura Medical Company Profile

(Get Free Report)

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.